Bing

SEARCH HISTORY

Healthcare stocks rose broadly on Wall Street so far on Wednesday, with the sector seeing an overall increase of 0.4%. More broadly, the Dow Jones Industrial Average rose 0.2%, the Nasdaq pushed 0.5% higher and the S&P 500 climbed 0.2%. Some of …
Investor Place · 4/9/2014
Investors in Questcor Pharmaceuticals Inc (NASD: QCOR) saw new options begin trading today, for the November 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the QCOR options chain for the new November 1st …
Forbes · 10/3/2013
ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial. Highlights from the ratings report include: QCOR's very impressive revenue growth greatly …
The Street · 10/19/2012
More from Bing News
Questcor Pharmaceuticals, Inc. ( QCOR) was a big mover last session, as the company saw its shares shoot up nearly 19% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This …
NASDAQ · 4/8/2014
A bit of background; In March and April of 09, QCOR was trading between $4.50 and $5.50. The stock dipped in May below $3.50 and then staged a steady rally over the next 4-Months closing above $6.50. QCOR then nosedived past $3.50 in the next …
Smallcap Network · ByDennis Askew · 3/3/2010
Upcoming Aetna Policy Update has little downside, but lots of potential upside. Getting long QCOR now appears to make sense as the next major catalyst is Aetna's anticipated Policy Update on October 13th, which everyone expects will remain negative …
Reuters · 10/2/2012
Questcor Pharmaceuticals, Inc. (QCOR) is going all crazy'n stuff today following kick-butt quarter. Robust sales for Acthar put to rest worries that reimbursement issues for newer uses of the drug might restrict sales, and the stock is up more than 30% as ...
istock Analyst · 7/31/2013
Acthar is not a first-line therapy for MS or Nephrotic Syndrome ... Our view is that the sell-off is overdone and that a fair price for QCOR stock lies somewhere between the recent lows around $18 and previous highs of $50. Should QCOR's sales trajectory ...
Seeking Alpha · 10/18/2012
Questcor Pharmaceuticals, Inc. (QCOR) was a big mover last session, as the company saw its shares shoot up nearly 19% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This broke …
Yahoo Finance · 4/8/2014
QCOR) investors: listen up. In today’s marketplace, there are a multitude of methods shareholders can use to watch stocks. A pair of the most under-the-radar are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that ...
INSIDER MONKEY · 8/27/2013